Your session is about to expire
← Back to Search
Anti-Snoring Appliances for Airway Blockage and Snoring during Sedation
Study Summary
This trial will test if using anti-snoring appliance devices can reduce airway interventions during sedation.
- Sedation Complication
- Airway Blockage
- Snoring
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a high score on the STOP-BANG survey.
- Group 1: Group #1: Anti-snoring appliance
- Group 2: Group #2: Control group, that will not utilize anti-snoring appliance
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there an age cap for eligibility in this medical research?
"This trial is available for patients aged between 18 and 89. There are 10 studies targeting minors, while persons over 65 can participate in 22 different trials."
Is the enrollment process still open for this experiment?
"An examination of the clinicaltrials.gov database reveals that recruitment for this study is ongoing, with a publication date of February 14th 2023 and last edits made on February 25th 2023."
How many people are being recruited for participation in this clinical research?
"Affirmative. Clinicaltrials.gov indicates that this clinical trial, first announced on February 14th 2023, is currently enrolling patients. 28 individuals need to be registered from 1 site for the study to proceed as planned."
Am I eligible for enrollment in this clinical trial?
"Applicants must meet two criteria to be considered for this medical trial - they should have airway blockage and an age between 18-89 years old. The study is aiming to enrol 28 patients in total."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger